Novare Capital Management LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAH) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 42,956 shares of the company’s stock, valued at approximately $2,875,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Alpha Windward LLC boosted its stake in shares of Cardinal Health by 0.7% in the 2nd quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after buying an additional 17 shares during the last quarter. Security National Bank of Sioux City Iowa IA boosted its stake in shares of Cardinal Health by 0.3% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 13,255 shares of the company’s stock worth $1,033,000 after buying an additional 40 shares during the last quarter. Wetherby Asset Management Inc. boosted its stake in shares of Cardinal Health by 0.5% in the 2nd quarter. Wetherby Asset Management Inc. now owns 8,392 shares of the company’s stock worth $654,000 after buying an additional 44 shares during the last quarter. Bessemer Group Inc. boosted its stake in shares of Cardinal Health by 1.2% in the 2nd quarter. Bessemer Group Inc. now owns 4,238 shares of the company’s stock worth $330,000 after buying an additional 51 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Cardinal Health by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 23,468 shares of the company’s stock worth $1,829,000 after buying an additional 68 shares during the last quarter. Hedge funds and other institutional investors own 88.64% of the company’s stock.

A number of equities analysts have recently issued reports on the company. Argus downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Wednesday. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Jefferies Group LLC lowered their target price on Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Mizuho set a $70.00 target price on Cardinal Health and gave the company a “hold” rating in a research report on Tuesday, October 24th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cardinal Health in a research report on Thursday, October 12th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and five have assigned a buy rating to the company’s stock. Cardinal Health currently has a consensus rating of “Hold” and a consensus price target of $74.81.

Cardinal Health, Inc. (NYSE CAH) traded up $0.59 during trading hours on Friday, reaching $57.42. The company’s stock had a trading volume of 4,960,000 shares, compared to its average volume of 2,364,550. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35. The company has a market capitalization of $18,100.00, a PE ratio of 10.78, a PEG ratio of 1.64 and a beta of 0.88. Cardinal Health, Inc. has a twelve month low of $55.69 and a twelve month high of $84.88.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.09. The business had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The business’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $1.24 earnings per share. research analysts forecast that Cardinal Health, Inc. will post 4.97 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd will be issued a dividend of $0.4624 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.85 dividend on an annualized basis and a yield of 3.22%. Cardinal Health’s dividend payout ratio is presently 53.94%.

ILLEGAL ACTIVITY WARNING: “Novare Capital Management LLC Invests $2.88 Million in Cardinal Health, Inc. (CAH)” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/novare-capital-management-llc-invests-2-88-million-in-cardinal-health-inc-cah/1709905.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.